CABASER 0.5 - Adelphi Research

Beyond hyperprolactinemia, Cabergoline is occasionally prescribed for pituitary adenomas, where it reduces prolactin levels directly from the pituitary lactotropes. This targeted approach offers effective symptom management and can decrease tumor size over time. The use of Cabergoline in pituitary-related conditions underscores its utility as a non-surgical intervention in cases where prolactin-producing tumors are present. While primarily used for prolactin control, Cabergoline’s effects on tumor activity make it a valuable tool for certain endocrine tumors​.

Disclaimer: Information provided it this page is for general information only and does not substitute for professional medical advice.

For detailed information about CABASER 0.5 by Adelphi Research, consult with your doctor or healthcare professional.